Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• The MET receptor tyrosine kinase is frequently overexpressed in human osteosarcomas.
• MET signaling pathways regulate crucial cellular processes like proliferation, migration, and morphogenesis.

Purpose of the Study:

• To investigate the role of HGF-MET signaling in osteosarcoma cell proliferation and invasion.
• To elucidate the specific downstream pathways activated by HGF in osteosarcoma cells.

Main Methods:

• Analysis of HGF-dependent activation of MAPK and PKB/AKT pathways in five human osteosarcoma cell lines.
• Assessment of proliferation and invasion responses following HGF stimulation.
• Evaluation of the effects of the MET inhibitor K252a on HGF-induced responses.

Main Results:

• All tested osteosarcoma cell lines expressed high levels of the MET proto-oncogene.
• HGF stimulation activated the MAPK pathway in four cell lines, correlating with increased proliferation.
• HGF also activated the PKB/AKT pathway in two cell lines, linked to enhanced invasive-motile responses.
• The MET inhibitor K252a effectively reversed both HGF-induced proliferation and invasion.

Conclusions:

• HGF activates both mitogenic (MAPK) and motogenic (PKB/AKT) pathways in osteosarcoma cells.
• MET receptor signaling plays a significant role in promoting the malignant behavior of osteosarcoma cells.
• Targeting the HGF-MET pathway with inhibitors like K252a holds potential for osteosarcoma treatment.